Switch Protein News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Switch Protein. Real-time updates on events, politics, business and more.

Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond ...

May 21, 2024

Planegg/Martinsried, May 21, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of differentiated T cell immunotherapies for

Pamela Keck Planegg Martinsried Prime Standard Chief Executive Officer End To Platform Switch Proteins

Source: smdailyjournal.com

Medigene presents streamlined 6-day, high stemness TCR-T therapy production process

April 25, 2024

Planegg/Martinsried, April 25, 2024. Medigene AG , an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, today presents a...

New York United States City Of United Kingdom Kirsty Crame Pamela Keck

Source: marketscreener.com

Medigene presents rationale for combining its 3S TCRs with enhancement tools as an approach to ...

August 30, 2023

Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard) is an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors. Prof. Dolores

Pamela Keck Dolores Schendel Hongsheng Sciences Prime Standard Chief Scientific Officer Switch Receptors

Source: smdailyjournal.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Switch Protein News Today

Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond ...

Medigene presents streamlined 6-day, high stemness TCR-T therapy production process

Medigene presents rationale for combining its 3S TCRs with enhancement tools as an approach to ...

Explore More Categories